| Literature DB >> 30256430 |
Zi-Li Ren1, Hao Liu1, Di Jiao1, Hao-Tian Hu1, Wei Wang1, Jie-Xiu Gong1, Ai-Li Wang1, Hai-Qun Cao2, Xian-Hai Lv1,3.
Abstract
Hit, Lead & Candidate Discovery To discover succinate dehydrogenase inhibitors with a novel structure, we introduced cinnamic acid structure to optimize the lead structure 1 and synthesized four series of cinnamon-pyrazole carboxamide derivatives. The bioassay data showed that compounds (E)-N-(1-[4-chlorophenyl]-4-cyano-1H-pyrazol-5-yl)-3-(2-fluorophenyl) acrylamide (5III-d) and (E)-3-(2-chlorophenyl)-N-(1-[4-chlorophenyl]-4-cyano-1H-pyrazol-5-yl) acrylamide (5III-f) showed the significant antifungal activity against three fungi. In addition, 5III-d and 5III-f exhibited the excellent inhibitory effect against succinate dehydrogenase (SDH) enzymes with IC50 values ranging from 19.4 to 28.7 μM. The study demonstrates that the chlorine substituent group is present on both the phenyl and pyrazole rings that have a very good effect on the antifungal effect, and the compounds 5III-d and 5III-f can act as potential SDH inhibitors (SDHI) and throw a sprat for a new generation of SDHI.Entities:
Keywords: 3D-QSAR; cinnamamide; fungicidal activity; molecular docking; pyrazole; succinate dehydrogenase inhibitors
Mesh:
Substances:
Year: 2018 PMID: 30256430 DOI: 10.1002/ddr.21469
Source DB: PubMed Journal: Drug Dev Res ISSN: 0272-4391 Impact factor: 4.360